Human Immunoglobulin for Intravenous Injection Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19)
1.2 Key Market Segments
1.2.1 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Segment by Type
1.2.2 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Overview
2.1 Global Market Overview
2.1.1 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Competitive Landscape
3.1 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Manufacturers (2019-2024)
3.2 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Sites, Area Served, Product Type
3.6 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Competitive Situation and Trends
3.6.1 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Industry Chain Analysis
4.1 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Type (2019-2024)
6.3 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Market Share by Type (2019-2024)
6.4 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Price by Type (2019-2024)
7 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Sales by Application (2019-2024)
7.3 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size (M USD) by Application (2019-2024)
7.4 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Growth Rate by Application (2019-2024)
8 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Segmentation by Region
8.1 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Region
8.1.1 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Region
8.1.2 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Region
8.2 North America
8.2.1 North America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Boya-Bio
9.1.1 Boya-Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
9.1.2 Boya-Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
9.1.3 Boya-Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Market Performance
9.1.4 Boya-Bio Business Overview
9.1.5 Boya-Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) SWOT Analysis
9.1.6 Boya-Bio Recent Developments
9.2 Beijing Tiantan Biological Products
9.2.1 Beijing Tiantan Biological Products Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
9.2.2 Beijing Tiantan Biological Products Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
9.2.3 Beijing Tiantan Biological Products Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Market Performance
9.2.4 Beijing Tiantan Biological Products Business Overview
9.2.5 Beijing Tiantan Biological Products Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) SWOT Analysis
9.2.6 Beijing Tiantan Biological Products Recent Developments
9.3 Hualan Bio
9.3.1 Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
9.3.2 Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
9.3.3 Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Market Performance
9.3.4 Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) SWOT Analysis
9.3.5 Hualan Bio Business Overview
9.3.6 Hualan Bio Recent Developments
9.4 Guangdong Shuagnlin Bio-pharmacy
9.4.1 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
9.4.2 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
9.4.3 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Market Performance
9.4.4 Guangdong Shuagnlin Bio-pharmacy Business Overview
9.4.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments
9.5 Weiguang Biological
9.5.1 Weiguang Biological Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
9.5.2 Weiguang Biological Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
9.5.3 Weiguang Biological Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Market Performance
9.5.4 Weiguang Biological Business Overview
9.5.5 Weiguang Biological Recent Developments
9.6 Sinopharm
9.6.1 Sinopharm Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
9.6.2 Sinopharm Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
9.6.3 Sinopharm Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Market Performance
9.6.4 Sinopharm Business Overview
9.6.5 Sinopharm Recent Developments
9.7 Shanghai RAAS
9.7.1 Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
9.7.2 Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
9.7.3 Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Market Performance
9.7.4 Shanghai RAAS Business Overview
9.7.5 Shanghai RAAS Recent Developments
9.8 CTBB
9.8.1 CTBB Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
9.8.2 CTBB Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
9.8.3 CTBB Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Market Performance
9.8.4 CTBB Business Overview
9.8.5 CTBB Recent Developments
9.9 Nanyue Biopharming
9.9.1 Nanyue Biopharming Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
9.9.2 Nanyue Biopharming Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
9.9.3 Nanyue Biopharming Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Market Performance
9.9.4 Nanyue Biopharming Business Overview
9.9.5 Nanyue Biopharming Recent Developments
10 Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Forecast by Region
10.1 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast
10.2 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Country
10.2.3 Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Region
10.2.4 South America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) by Type (2025-2030)
11.1.2 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) by Type (2025-2030)
11.2 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Forecast by Application (2025-2030)
11.2.1 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons) Forecast by Application
11.2.2 Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Comparison by Region (M USD)
Table 5. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) as of 2022)
Table 10. Global Market Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Sites and Area Served
Table 12. Manufacturers Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Type
Table 13. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Challenges
Table 22. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Type (Kilotons)
Table 23. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size by Type (M USD)
Table 24. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Type (2019-2024)
Table 26. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Share by Type (2019-2024)
Table 28. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons) by Application
Table 30. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size by Application
Table 31. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Application (2019-2024)
Table 33. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Share by Application (2019-2024)
Table 35. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Region (2019-2024)
Table 38. North America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales by Region (2019-2024) & (Kilotons)
Table 43. Boya-Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
Table 44. Boya-Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
Table 45. Boya-Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Boya-Bio Business Overview
Table 47. Boya-Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) SWOT Analysis
Table 48. Boya-Bio Recent Developments
Table 49. Beijing Tiantan Biological Products Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
Table 50. Beijing Tiantan Biological Products Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
Table 51. Beijing Tiantan Biological Products Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Beijing Tiantan Biological Products Business Overview
Table 53. Beijing Tiantan Biological Products Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) SWOT Analysis
Table 54. Beijing Tiantan Biological Products Recent Developments
Table 55. Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
Table 56. Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
Table 57. Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Hualan Bio Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) SWOT Analysis
Table 59. Hualan Bio Business Overview
Table 60. Hualan Bio Recent Developments
Table 61. Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
Table 62. Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
Table 63. Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Guangdong Shuagnlin Bio-pharmacy Business Overview
Table 65. Guangdong Shuagnlin Bio-pharmacy Recent Developments
Table 66. Weiguang Biological Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
Table 67. Weiguang Biological Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
Table 68. Weiguang Biological Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Weiguang Biological Business Overview
Table 70. Weiguang Biological Recent Developments
Table 71. Sinopharm Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
Table 72. Sinopharm Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
Table 73. Sinopharm Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Sinopharm Business Overview
Table 75. Sinopharm Recent Developments
Table 76. Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
Table 77. Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
Table 78. Shanghai RAAS Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Shanghai RAAS Business Overview
Table 80. Shanghai RAAS Recent Developments
Table 81. CTBB Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
Table 82. CTBB Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
Table 83. CTBB Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CTBB Business Overview
Table 85. CTBB Recent Developments
Table 86. Nanyue Biopharming Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Basic Information
Table 87. Nanyue Biopharming Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Product Overview
Table 88. Nanyue Biopharming Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Nanyue Biopharming Business Overview
Table 90. Nanyue Biopharming Recent Developments
Table 91. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size (M USD), 2019-2030
Figure 5. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size (M USD) (2019-2030)
Figure 6. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size by Country (M USD)
Figure 11. Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Share by Manufacturers in 2023
Figure 12. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Revenue Share by Manufacturers in 2023
Figure 13. Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Share by Type
Figure 18. Sales Market Share of Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) by Type (2019-2024)
Figure 19. Sales Market Share of Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) by Type in 2023
Figure 20. Market Size Share of Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) by Type (2019-2024)
Figure 21. Market Size Market Share of Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Share by Application
Figure 24. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Application (2019-2024)
Figure 25. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Application in 2023
Figure 26. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Share by Application (2019-2024)
Figure 27. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Share by Application in 2023
Figure 28. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Region (2019-2024)
Figure 30. North America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Country in 2023
Figure 32. U.S. Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Country in 2023
Figure 37. Germany Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Region in 2023
Figure 44. China Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (Kilotons)
Figure 50. South America Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Country in 2023
Figure 51. Brazil Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Sales Forecast by Application (2025-2030)
Figure 66. Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Share Forecast by Application (2025-2030)
Industry Market Size
